Capital World Investors
EW icon

Capital World Investors’s Edwards Lifesciences EW Stock Holding History

Capital World Investors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-32,636,400
Closed -$693M – 531
2014
Q4 		$693M Sell
32,636,400
-3,240,000
-9% -$65.1M 0.19% 131
2014
Q3 		$611M Sell
35,876,400
-36,864,000
-51% -$582M 0.17% 134
2014
Q2 		$1.04B Sell
72,740,400
-2,400,000
-3% -$32.5M 0.29% 91
2014
Q1 		$929M Sell
75,140,400
-4,896,000
-6% -$56.5M 0.26% 100
2013
Q4 		$877M Sell
80,036,400
-3,786,000
-5% -$42.7M 0.25% 106
2013
Q3 		$973M Sell
83,822,400
-300,000
-0.4% -$3.51M 0.3% 94
2013
Q2 		$942M Buy
+84,122,400
New +$996M 0.31% 89

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors's EW Position: Q1 2015 in Review

Capital World Investors sold out of Edwards Lifesciences (EW) in Q1 2015, closing a stake of 32,636,400 shares — an estimated $693M sold.

Capital World Investors first reported a position in EW in Q2 2013 and held it in 7 quarters. The position peaked at $1.04B in Q2 2014. 576 funds tracked by Wall St. Rank hold EW as of Q1 2015.

  • Capital World Investors reported no remaining Edwards Lifesciences position as of Q1 2015 after selling out during the quarter.
  • Capital World Investors sold 32,636,400 Edwards Lifesciences shares in Q1 2015, an estimated $693M.
  • Capital World Investors first reported a position in Edwards Lifesciences in Q2 2013 and held it in 7 quarters.
  • Capital World Investors's Edwards Lifesciences position peaked at $1.04B in Q2 2014.
  • 576 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2015.

Based on Capital World Investors's 13F filing for Q1 2015, filed 15 May 2015.